Authors

  • Маржона Рамазоновна Аслонова

Keywords:

SARS CоV-2, пневмония, сахарный диабет 2 типа, пневмония, интерферон.

References

Clerkin K.J., Fried J.A., Raikhelkar J., Sayer G., Griffin J.M., Masoumi A. et al. Coronavirus disease 2019 (COVID-19) and cardiovasculardisease // Circulation. 2020. Vol. 141. P. 1648–1655. DOI: https://doi. org/10.1161/ CIRCULATIONAHA. 120.046 941

Clerkin K.J., Fried J.A., Raikhelkar J., Sayer G., Griffin J.M., Masoumi A. et al. Coronavirus disease 2019 (COVID-19) and cardiovasculardisease // Circulation. 2020. Vol. 141. P. 1648–1655. DOI: https://doi.org /10.1161/CIRCULATIONAHA.120.046941

Guo W., Li M., Dong Y., Zhou H., Zhang Z., Tian C. Diabetes is a riskfactor for the progression and prognosis of COVID-19 // Diabetes Metab. Res.Rev. 2020. Mar 31. Article ID e3319. DOI: https://doi.org/10. 1002/dmrr.3319

Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y. Clinical features ofpatients infected with 2019 novel coronavirus in Wuhan, China // Lancet.2020. Vol. 395. P. 497–506

Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China // Lancet.2020. Vol. 395. P. 497–506

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al.,2020; Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, et al.,2019

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al.,2020

H4ui DS, Zumla A,2019; Yin Y, Wunderink RG,2018; Hui DS, Memish ZA, Zumla A.,2014; Badawi A, Ryoo SG.,2016]

Hui DS, Zumla A.,2019; Yin Y, Wunderink RG.2018; Hui DS, Memish ZA, Zumla A,2014

Jeong I.K., Yoon K.H., Lee M.K. Diabetes and COVID-19: global andregional perspectives // Diabetes Res. Clin. Pract. 2020. Vol. 166. ArticleID 108303. PMCID: PMC 7332438 PMID: 32623038

Richardson S., Hirsch J.S., Narasimhan M., Crawford J.M., McGinn T.,Davidson K.W. et al.; the Northwell COVID-19 Research Consortium. Presenting characteristics, comorbidities, and outcomes among 5700 patientshospitalized with COVID-19 in the New York City Area // JAMA. 2020. Vol.323, N 20. P. 2052–2059. DOI: https://doi.org/10.1001/jama.2020. 6775Erratum in: JAMA. 2020. Vol. 323, N 20. P. 2098. PMID: 32320003; PMCID:PMC 7177629]

Russell B, Moss C, Rigg A, Hemelrijck MV. COVID-19 andtreatment with NSAIDs and corticosteroids: should we belimiting their use in the clinical setting? Ecancer. 2020;14:1023.doi: https://doi.org /10.3332/ecancer.2020.1023].

Roncon L., Zuin M., Rigatelli G., Zuliani G. Diabetic patients withCOVID-19 infection are at higher risk of ICU admission and poor shorttermoutcome // J. Clin. Virol. 2020. Vol. 127. Article ID 104354

World Health Organization Coronavirus Disease (COVID-2019) Situation Reports 158. Geneva: WHO; (2020). [Google Scholar

World Health Organization Naming the coronavirus disease (COVID-19) and the virus that causes it [EB/OL] 2020-02-11. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technicalguidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causesit [Ref list]

World Health Organization Coronavirus disease 2019 (COVID-19) situation report – 92. https://www.who.int/docs/ default-source / coronaviruse / situation reports 20200421-sitrep-92-covid-19.pdf? sfvrsn=38e6b06d_6

Zhao Z, Zhang F, Xu M, et al. De-scription and clinical treatmentof an early outbreak of severe acute respiratory syndrome (SARS)in Guangzhou, PR China. J Med Microbiol. 2013;52(Pt 8):715–720. https:// doi.org/10.1099/jmm.0.05320-0

Zhu L., She Z.G., Cheng X., Qin J.J., Zhang X.J., Cai J. et al. Association of blood glucose control and outcomes in patients withCOVID-19 and pre-existing type 2 diabetes // Cell Metab. 2020. Vol. 31,N 6. P. 1068–1077.e3. DOI: https://doi.org/10. 1016/j.cmet.2020.04.021PMID: 32369736; PMCID: PMC 7252168

Всемирная организация здравоохранения (2018 г.) Глобальный доклад о диабете. https:// www.who.int / news-room/fact-sheets/detail/diabetes. По состоянию на 17 марта 2020 г.

Демидов Н.А., Андреева А.В., Анциферов М.Б. Сахарный диабет и COVID-19 в Москве: cтатус 2020 г. // Эндокринология: новости, мнения, обучение. 2021. Т. 10, № 2. C. 32–40. DOI: https://doi.org/ 10.33029/2304-9529-2021-10-2-32-40

Демидов Н.А., Андреева А.В., Анциферов М.Б. Сахарный диабет и COVID-19 в Москве: cтатус 2020 г. // Эндокринология: новости, мнения, обучение. 2021. Т. 10, № 2. C. 32–40. DOI: https://doi.org/ 10.33029/2304-9529-2021-10-2-32-40

Пономарева А.А. Прогностические факторы риска клинических исходов пациентов с сахарным диабетом 2 типа и новой коронавирусной инфекцией // Эндокринология: новости, мнения, обучение. 2021. Т. 10, № 3. C. 106–108. DOI: https://doi.org/10.33029/2304-9529-2021-10-3-106-108

Хайдарова Ф.А., Алиева А.В., Бердыкулова Д.М., Алимова Н.У., Халилова Д.З., Тожиева И.М. Структура смертности среди пациентов с сахарным диабетом в Республике Узбекистан во время пандемии COVID-19 // Сахарный диабет. —2022. — Т. 25. — №4. — С. 322-326. doi: https://doi.org/10.14341/DM12786С